Oral etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster
Oral etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster

21 Şubat 2017 Salı

Diabetes and Oral Health Problems

Overview


During the past ten years, much research has been undertaken on the link between periodontal disease and diabetes. The periodontal disease is the sixth leading complication of diabetes and if you have been diagnosed with it, then you are three to four times more likely to develop it. You are at a higher risk for more severe levels of gum infection and bone loss.


The more severe form of gum disease is called as periodontitis. When you reach this stage, the gums start to pull away from your teeth. The pockets form between the gums and teeth and these will fill with pus and germs and deepen. When this happens, you;ll need the gum surgery in order to save your teeth. If nothing is done, then the infection will destroy the bone around the teeth. The teeth will then start to move or begin to loose. Then the teeth may fall out or need to be pulled.


Is There an Association Between Gum Disease and Diabetes?


Nearly 30 million Americans have diabetes and most of them may be surprised to learn about the unexpected complicated related with it. As per research, there is an increased prevalence of the gum disease among those with diabetes. It also add serious gum disease to the list of other associated complications such as stroke, heart disease and kidney disease.


Is There a Two-Way Street?


The emerging research suggests that the relation between serious gum disease and diabetes is a two way street. People with diabetes are more susceptible to serious gum diseases that have the potential to affect the blood glucose control and contribute to the progression of diabetes. The research also suggests that people with diabetes are at higher risk for oral health problems such as gingivitis which is an early stage of gum disease and periodontitis which is a serious gum disease.


The reason why people with diabetes are at higher risk for serious gum disease is that they are more susceptible to the bacterial infection and have a decreased ability to fight the bacteria which invades the gum. The Surgeon General’s Report on Oral Health states that the good oral health is an integral part to the general health. Ensure to brush and floss properly and visit your dentist for regular checkups.


If I Have Diabetes, am I at Risk for Dental Problems?


If your blood glucose levels are poorly controlled then you are more likely to develop serious gum diseases and lose more teeth than the non-diabetics. Unlike all the infections, serious gum disease may be a factor causing the blood sugar level to rise and make harder to control the diabetes. Other oral health problems related to diabetes are: dry mouth which can cause soreness, ulcers, thrush, an infection caused by fungus which grows in the mouth, infections and cavities.


How Can I Help Prevent Dental Problems Associated with Diabetes?


Control your blood glucose level. Take good care of the teeth and gums, along with a regular checkup every six months. Maintain good diabetic control to control fungal infection and thrush. Avoid smoking. Remove and clean dentures daily if you wear them. Good blood glucose control helps to prevent or relieve the dry mouth caused by diabetes.


What Can I Expect at My Checkup? Should I Tell My Dental Professional About My Diabetes?


 Dentists and hygienist are equipped to meet the special needs of people with diabetes. Keep your dentists and hygienist informed about any changes in your condition. If your blood sugar level is not in good control then postpone any non-emergency dental procedures.


 Source:


http://www.artipot.com/articles/1917325/how-weight-loss-surgery-helps-type-2-diabetes.htm


https://health-care-treatment.quora.com/What-Is-the-Link-Between-Type-2-Diabetes-and-Oral-Health


http://www.empowher.com/community/share/why-you-should-get-oral-health-advice-expert-dentist



Diabetes and Oral Health Problems

15 Haziran 2014 Pazar

Constructive Outcomes For New Oral Drug From Actelion

Actelion has announced positive leading-line benefits for a phase III trial of a new oral drug for the therapy of pulmonary arterial hypertension (PAH). The drug, selexipag, is a first-in-class orally offered selective prostacyclin IP receptor agonist.


The pivotal, double-blind GRIPHON study was the greatest end result trial ever performed in PAH. 1,156 PAH sufferers have been randomized to selexipag or placebo. The company said that trial had “met its major efficacy endpoint with high statistical significance.” After followup of up to 4.3 years, selexipag lowered the threat of a morbidity or mortality event by 39% (p&lt0.0001). The final results had been steady across the important subgroups of age, gender, WHO functional class, PAH etiology and background therapy. Endpoint events were adjudicated by a blinded independent committee.


Actelion reported that 14% of sufferers in the selexipag group and 7% of sufferers in the placebo group discontinued therapy due to adverse occasions. The most common adverse occasions linked with selexapig were related to people noticed with prior prostacyclin therapies, like headache, diarrhea, nausea, jaw ache, vomiting, pain in extremity, myalgia, nasopharyngitis and flushing.


Most sufferers in the study were taking other oral PAH medicines at the begin of the research.


“I have been prescribing intravenous prostacyclin therapies in PAH individuals for nearly twenty many years. Today’s GRIPHON results represent a main phase forward. For the 1st time, with selexipag, we have an oral compound acting on the prostacyclin pathway showing a considerable risk reduction on a hugely clinically related endpoint,” said Gérald Simonneau, a member of the trial’s steering committee, in the Actelion press release.


John Ryan, an professional on PAH at the University of Utah, expressed enthusiasm for the information:



This is an thrilling trial and an intriguing end result, specifically when contemplating the size of the research, the prolonged follow-up and the substantial percentage of individuals previously on background therapy. Getting an oral agent in PAH that substantially impacted mortality/morbidity represents a key phase forward and could be a actual game changer in this aggressive and fatal condition.




Constructive Outcomes For New Oral Drug From Actelion

7 Nisan 2014 Pazartesi

Boehringer Ingelheim"s Oral Anticoagulant Gains New Indication

The new oral anticoagulants carry on to achieve extra indications from the FDA. Earlier these days Boehringer Ingelheim announced that the FDA had accredited Pradaxa (dabigatran) for the treatment of venous thromboembolism (VTE), which includes each deep venous thrombosis (DVT) and pulmonary embolism (PE).


Last month Bristol-Myers Squibb’s and Pfizer’s Eliquis (apixaban) gained an indication for VTE prophylaxis following hip or knee substitute surgical procedure. Johnson &amp Johnson’s Xareleto (rivaroxaban) had presently received this indication. Hence, all 3 of the new oral anticoagulants have now received FDA approval for the main indications of stroke prevention in patients with nonvalvular atrial fibrillation (SPAF), DVT prophylaxis following hip or knee substitute surgical procedure, and treatment method of folks who have or have had VTE.


1 significant variation in the VTE treatment labels is that both Eliquis and Xarelto have been studied using a single-drug approach. These medication are authorized for acute use in the hospital and for continued use afterwards. By contrast, Pradaxa was studied in individuals after they had received parenteral anticoagulants and is indicated for use following therapy with a parenteral anticoagulant for five to 10 days. It can also be utilised in individuals who have been previously treated for VTE.


“Venous thromboembolism is the third most typical cardiovascular disease soon after myocardial infarction and stroke. About one-third of patients with a DVT or PE will suffer a recurrence inside of 10 years,” stated Samuel Z. Goldhaber, in a Boehringer Ingelheim press release. “Dabigatran has established efficacy and security for stroke danger reduction in individuals with non-valvular atrial fibrillation. This new FDA approval expands dabigatran’s indications to consist of therapy and the reduction of the chance of recurrence of DVT and PE.”


The new indication is based mostly on outcomes from four global Phase III scientific studies evaluating the efficacy and safety of Pradaxa in the therapy of DVT and PE: RE-COVER, RE-COVER II, RE-MEDYSM, and RE-SONATE.



Boehringer Ingelheim"s Oral Anticoagulant Gains New Indication

8 Mart 2014 Cumartesi

Simple Oral Care for Individuals Can Save Lives

It is so wonderful that one thing as straightforward as basic oral care (I feel they are just talking about brushing teeth and rinsing with a very good antiseptic rinse), could have this sort of an impact on hospital contracted pneumonia and it is actual final result.  So hopefully this type of info may possibly make it to the mainstream so that patient’s households can get on board in locations where this kind of service is not becoming offered and aid patients that cannot usually do these standard care things for themselves.


In a recent report written by Pauline Bartolone on Capital Public Radio, the findings of a specialty group were alarming.


Nurses at personal hospitals, Veterans Affairs and a university teamed up to search at the prices of hospital-acquired pneumonia in individuals who aren’t on ventilators. “Hospitals weren’t going to be paid if sufferers on ventilators acquired pneumonia,” she says. “Meanwhile, the other individuals that weren’t on the ventilators have been also obtaining pneumonia, but not getting the identical volume of consideration.”


Baker says the team designed a 12 months-prolonged plan of simple oral care for sufferers at 1 hospital technique. At the finish of the yr, pneumonia prices went down by 37 %.


“Oral wellness care was the most modifiable. We felt it would be the best to apply, and its fundamental nursing care, and ought to be happening,” says Baker. “So we just believed, let’s begin with that! And we had these fantastic results.”


The nurse group estimated that eight deaths were prevented, almost two million dollars had been saved, and 500 hospital days had been averted.


An additional way that patients can be protected although on a hospital stay is the use of Vital Oil Aromatherapy.  The implementation of diffusing Younger Residing Thieves Oil in the sufferers area is growing nationwide.  Over 50 key hospitals in the US are using crucial oils.  This anti-fungal, anti-bacterial and anti-viral vital oil can also support shield sufferers and their visiting household members from contracting airborne illnesses whilst in the hospital.


The charge nurse became a licensed aromatherapist and is now a member of each the Nationwide Association of Holistic Aromatherapists and the Alliance of Worldwide Aromatherapists, and has accomplished a great task of clinically integrating important oils into our daily practice. In order to insure steady quality, we use Youthful Living Oils solely. Most of the oils are employed Neat, (undiluted), and others are diluted with additional virgin olive oil based on each and every situation. We also diffuse Younger Living Vital Oils at nursing stations, in our PACU, physician’s lounges, and in some offices.


We frequently treat gout, neuropathy, carpel tunnel, sinusitis, headaches, stomach pain, kidney stone discomfort, neuralgia, tennis elbow, arthritis, back pain, leg cramps, publish-op hip and knee soreness and no matter what else comes our way. Each patient’s need to have, which includes which Youthful Residing Essential Oils were used, is documented in our elec tronic charting so we can track their outcomes. We usually have a good stock of lavender, pep­permint, Peace and Calming, lemongrass, Thieves and plenty of single oils to make blends for gout. (Cleveland Clinic, Integrative Therapies Crew)  Learn a lot more about these Vital Oils.


Pass this on to anyone that has loved one’s in the hospital to aid them in avoiding their loved ones from obtaining sicker although in the hospital.


Wholesome Living Site



Simple Oral Care for Individuals Can Save Lives

31 Ocak 2014 Cuma

Oral Immunotherapy May Hold Guarantee For Youngsters With Peanut Allergy

Primarily based on final results of a phase II trial recently published in in Lancet, oral immunotherapy (OIT) in children with peanut allergy is linked with a substantial charge of desensitization.  Desensitization indicates that a kid will have no response when he or she eats peanuts- such as itching, hives or any much more severe signs and symptoms this kind of as lip or tongue swelling.


This suggests that this mode of therapy may possibly probably be beneficial with people struggling from peanut allergy, a life threatening and probably deadly foods allergy.


One particular hundred children between the ages of 7 and sixteen with peanut allergy have been randomized to normal care (avoiding peanuts) or 26 weeks of oral immunotherapy.  This consisted of daily doses of peanut flour which elevated over a period of time, up to a maintenance dose of 800 mg/day.


Benefits from the trial indicate that following 26 weeks, 62% of patients in the treatment method group have been desensitized. This signifies that no response was reported in the course of a blinded foods challenge of 1400 mg.  Based on results, no individuals in the control group were desensitized.  Itching  in and all around the mouth was the most widespread side result mentioned and occurred after six% of doses administered. Intramuscular epinephrine had to be administered two occasions throughout the trial, with no deaths or problems reported.


Despite the fact that OIT for peanut allergy is not appropriate for mainstream clinical use, the results from this trial are really encouraging.  Undoubtedly more investigation demands to be done on the mechanism of action, such as short and long phrase effects of the treatment, outcomes, as effectively as greater scale testing of such protocols.


The bottom line is that this should be accomplished in a systematic and cautious way through cautiously designed trials to make an successful and lasting approach without having any outside industry pressures.


Meals Allergies-The Implications


Foods allergy is a probably life threatening as effectively as a life altering problem which impacts up to 15 million Americans. Although there are a number of probably lifestyle threatening therapies (epinephrine, antihistamines and steroids) for its profound signs, there is no “cure” to prevent anaphylaxis–potentially deadly response involving the release of histamine top to reduced blood stress airway swelling and inability to breath.  The reality is that a trace volume of a food substance can trigger deadly anaphylaxis inside of minutes of ingestion. Meals allergic reactions build when the body’s immune method mistakenly targets a harmless foods protein or an allergen and perceives it as a threat.


Mild signs can assortment from a red rash or hives, to eczema or gastrointestinal symptoms this kind of as nausea and vomiting or diarrhea or an itchy mouth or ears. Signs and symptoms of anaphylaxis consist of swelling of the lips or tongue or throat trouble swallowing along with shortness of breath or wheezing., or even reduced blood stress or reduction of consciousness. Epinephrine is the only medicine which can deal with and reverse the signs and symptoms of anaphylaxis. It can be provided as an auto injector-and can be offered at the 1st signal of any extreme allergic reaction. It is crucial to phone 911 and go to the nearest emergency department even if the symptoms seem to get started resolving because there may be a recurrence within a brief time period soon after the medications wears off.


While folks can be allergic to any type of food, eight foods account for practically 90 % of all allergic reactions to foods in the US. (egg, milk, peanut, tree nuts, wheat, fish, soy, shellfish). The bottom line is that a individual can develop a foods allergy anytime, at any age nevertheless, the affect on toddlers and kids along with their families, is most pronounced.


FARE to the Rescue


According to latest information from FARE (Food Allergy Study and Schooling), a top national organization based mostly in New York City, and focused to food allergy investigation, education, advocacy and awareness, 1 in 13 US youngsters has a food allergy- practically two kids for every classroom. In addition, virtually forty% of young children with foods allergies have currently experienced anaphylaxis. Every 3 minutes, a meals allergy will lead to an emergency division go to. An last but not least, there has been nearly a 50 percent enhance in childhood meals allergy symptoms between 1997 and 2011, top to 25 billion bucks per 12 months in related health expenses to treatment and diagnosis.


FARE’s mission and goals– to assist make a difference in the every day lives of those impacted by meals allergies– reaches far and broad.  Founded by Elliot Jaffe, FARE has manufactured considerable contributions in research, training, advocacy, as well as marketing awareness of food allergic reactions throughout not only the US, but also all through the globe.


According to John L. Lehr, CEO of FARE, “Our vision is to make the globe protected for men and women with foods allergy symptoms. We are committed to finding a remedy for meals allergy symptoms, and to retaining people with food allergic reactions risk-free and included”.


“In our pursuit of a cure, we invest in globe-class research to boost therapy and understanding of the disease. We have a strategic program centered on accelerating the development of safe therapies that will protect individuals from daily life-threatening reactions” explained Lehr.


Lehr explained that FARE is functioning to broaden the number of very competent centers conducting clinical research, and to boost the variety of therapies below study and the variety of clinical trials underway by facilitating the collaboration between analysis centers.



Oral Immunotherapy May Hold Guarantee For Youngsters With Peanut Allergy

28 Ocak 2014 Salı

Issues Persist In spite of Gains In Oral Anticoagulant Use

Although significant progress has been made in recent years, a new survey from the European Society of Cardiology finds that there are still too many atrial fibrillation patients who are not taking the best medications to reduce their elevated risk of stroke. Many elderly patients are not receiving oral anticoagulants– either traditional warfarin or one of the newer anticoagulants (Pradaxa, Boehringer Ingelheim, Xarelto, Johnson & Johnson; and Eliquis (Pfizer and BristolMyers Squibb)– and overall too many patients are still taking aspirin, despite the fact that it is not recommended for this group of patients.


In a paper published in the American Journal of Medicine, Gregory YH Lip and colleagues analyzed data from more than 3,100 patients surveyed in the Euro Observational Research Programme on Atrial Fibrillation from February 2012 to March 2013. They found that the use of oral anticoagulants has improved over the past decade. A large majority– 72%– received warfarin while only 8% received one of the newer oral antigcoaulants.


“Novel oral anticoagulant uptake is still a bit low, probably because of differences in regulatory approval, costs and access to drugs in different countries,” said Dr. Lip, in an ESC press release. “But the main point is that overall oral anticoagulant uptake as a whole has improved in the last 10 years.”


The authors expressed concern about the persistent high use of aspirin among patients in the survey. “The perception that aspirin is a safe and effective drug for preventing strokes in AF needs to be dispelled,” said Lip. “If anything, you could say that giving aspirin to patients with AF is harmful because it is minimally or not effective at stroke prevention, yet the risk of major bleeding or intracranial haemorrhage is not significantly different to well-managed oral anticoagulation.” Aspirin is commonly prescribed as an antiplatelet agent in patients with coronary artery disease, especially following an acute coronary syndrome. In the survey AF patients with coronary disease were eight time more likely to be taking aspirin.


A finding of particular concern was the underuse of oral anticoagulants in elderly patients. Said Lip: “Elderly patients are at the highest risk for stroke and yet they are given aspirin which is not recommended and potentially harmful. There is a perception that elderly patients do not do well on anticoagulation.” But, he said, warfarin is actually “far superior” to aspirin in these patients for the prevention of stroke.



Issues Persist In spite of Gains In Oral Anticoagulant Use